Literature DB >> 23185981

Exposure and risk assessment for ochratoxin A and fumonisins in Japan.

Y Sugita-Konishi1, Y Kamata, T Sato, T Yoshinari, S Saito.   

Abstract

The authors performed exposure and risk assessments based on surveillance studies of retail foods in Japan that were undertaken during the past six years (2004-2010). The exposure to ochratoxin A (OTA) and fumonisins (FBs) in different age groups, including toddlers and young children (1-6 years old), older children (7-14 years old), adolescents (15-19 years old) and adults (over 20 years old) was simulated, and the risk of these mycotoxins was evaluated by comparing the provisional maximum tolerated daily intake (PMTDI) for FBs and the provisional maximum tolerated weekly intake (PMTWI) for OTA established by the FAO/WHO Joint Export Committee on Food Additives. The exposure assessment for both mycotoxins in each age group in Japan indicated that the highest exposure occurred in toddlers and children, but in all cases the percentage of the PMTWI and PMTDI at the 99th percentile of exposure was less than 35% for OTA and 10% for FBs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23185981     DOI: 10.1080/19440049.2012.743190

Source DB:  PubMed          Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess        ISSN: 1944-0057


  2 in total

1.  A reproductive and developmental screening study of the fungal toxin ochratoxin A in Fischer rats.

Authors:  Genevieve S Bondy; Laurie Coady; Nikia Ross; Don Caldwell; Anne Marie Gannon; Keri Kwong; Stephen Hayward; David E Lefebvre; Virginia Liston; Jayadev Raju; Peter Pantazopoulos; Ivan Curran
Journal:  Mycotoxin Res       Date:  2018-07-04       Impact factor: 3.833

2.  Estimated dietary exposure to mycotoxins after taking into account the cooking of staple foods in Japan.

Authors:  Hisako Sakuma; Yasushi Watanabe; Hiroko Furusawa; Tomoya Yoshinari; Hajime Akashi; Hiroshi Kawakami; Shiro Saito; Yoshiko Sugita-Konishi
Journal:  Toxins (Basel)       Date:  2013-05-21       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.